BRKRP Company Profile and Key Details

NASDAQ : BRKRP

Bruker 6375% Mandatory Convertible Preferred Stock Series A

$323.59

-11.28-3.37%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A (BRKRP) stock declined over -3.37%, trading at $323.59 on NASDAQ, down from the previous close of $334.87. The stock opened at $329.72, fluctuating between $323.42 and $329.72 in the recent session.

Stock Snapshot

334.87

Prev. Close

49.09B

Market Cap

323.42

Day Low

N/A

P/E Ratio

N/A

EPS (TTM)

N/A

Cash Flow per Share

329.72

Open

151.7M

Number of Shares

329.72

Day High

68.01%

Free Float in %

N/A

Book Value

6.72K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Feb 05, 2026	328.79	330.93	323.42	323.59	6.91K
Feb 04, 2026	341.15	341.15	334.67	334.87	1.47K
Feb 03, 2026	333.40	339.80	333.40	335.15	54.24K
Feb 02, 2026	341.30	341.30	341.30	341.30	3.27K
Jan 30, 2026	343.94	348.40	343.94	346.85	4.98K
Jan 29, 2026	351.92	356.61	344.30	344.62	6.7K
Jan 28, 2026	367.00	367.00	361.49	361.49	426
Jan 27, 2026	375.00	375.00	370.90	370.90	3.67K
Jan 26, 2026	380.20	380.96	375.45	376.01	27
Jan 23, 2026	387.12	387.12	387.12	387.12	27
Jan 22, 2026	401.90	401.90	401.90	401.90	79
Jan 21, 2026	390.80	390.80	390.80	390.80	385
Jan 20, 2026	368.67	385.97	368.67	385.97	3.58K
Jan 16, 2026	377.59	377.59	377.59	377.59	105
Jan 15, 2026	377.09	380.06	377.09	380.06	699
Jan 14, 2026	376.62	376.62	376.62	376.62	754
Jan 13, 2026	406.70	406.70	384.18	386.51	85.65K
Jan 12, 2026	419.83	419.83	406.75	406.90	6.99K
Jan 09, 2026	401.55	401.55	401.55	401.55	3.2K
Jan 08, 2026	398.90	400.47	398.90	400.47	11.72K

Contact Details

Billerica, MA 01821

United States

https://www.bruker.com 978 663 3660

About Company

Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the following segments: Bruker Scientific Instruments (BSI) BioSpin, BSI Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID), BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The BSI BioSpin segment includes life science tools based on magnetic resonance technology. The BSI CALID segment focuses on life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments, and solutions based on infrared and Raman molecular spectroscopy technologies and radiological and nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection. The BSI Nano segment offers advanced x-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments, analytical tools for electron microscopes and x-ray metrology, defect-detection equipment for semiconductor process control, handheld, portable, and mobile x-ray fluorescence spectrometry instruments, spark optical emission spectroscopy systems, and chip cytometry products and services for targeted spatial proteomics, multi-omics services, and products and services for spatial genomics research. The BEST segment is involved in superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare, and big science research. The company was founded by Emil Bruker and G�nther Laukien in 1960 and is headquartered in Billerica, MA.

Stock Peers

SWAV

-0.08-0.02%

ShockWave Medical, Inc.$334.75 UFPT

0.92+0.36%

UFP Technologies, Inc.$256.21 PODD

-8.09-3.22%

Insulet Corporation$243.15 ALGN

14.32+8.88%

Align Technology, Inc.$175.62 IRTC

-5.71-3.75%

iRhythm Technologies, Inc.$146.75 TMDX

-0.77-0.59%

TransMedics Group, Inc.$129.60 IRMD

0.69+0.74%

IRadimed Corporation$94.54 NARI

Inari Medical, Inc.$79.97 AXNX

Axonics, Inc.$70.98 DXCM

-0.93-1.31%

DexCom, Inc.$69.89

Company Overview

Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A (NASDAQ:BRKRP) closed at $323.59 USD, losing -$11.28 (-3.37%) from the previous close of $334.87. The stock is currently mid-range between its 52-week high and low $250.00 and $419.83. With a market capitalization of about $49.09 billion, Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A is classified as a large-cap and shows market-like volatility (beta ~1.18). Key stats such as the average daily volume over the past year has been around 15.18 thousand shares, volume is running light vs its 52-week average. Headquartered in Billerica, MA, Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Frank H. Laukien, the company employs approximately 11,396 people and listed since September 08, 2025. Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels.

Technical Performance

Average 10-day trading volume of 9.08 thousand shares is below the 3-month average of 15.21 thousand, indicating normal recent market interest.

Valuation Metrics

Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A trades at a P/E ratio of -297.8, slightly below the S&P 500 average, with a price-to-sales ratio of 1.81 and a price-to-book ratio of 2.56 suggesting the stock is closer to book value. The P/FCF stands at -587.72, also below market averages.

Dividend & Fair Value

Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A last paid a dividend of 14.7 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $62.59. This means the shares are trading above this model’s fair value.

Earnings & Analyst Outlook

Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A earnings surprise history is a mixed track record. The quarter that ended November 03, 2025, missed forecasts by 27.23%.

Financial & Profitability Overview

Over the trailing twelve months, Bruker 6375% Mandatory Convertible Preferred Stock Series A has not generated any revenue.
On valuation metrics, Bruker 6375% Mandatory Convertible Preferred Stock Series A trades at a P/E of -297.80, P/S of 1.81 and P/B of 2.56. The current ratio is 1.85 and quick ratio is 0.91. Operationally, the company’s inventory turnover is 1.51 and cash conversion cycle is 275.56 days. Debt-to-equity is 0.84, supported by a cash flow-to-debt ratio of 0.05.

Price Forecast & Outlook

Our AI price prediction model suggests that Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Key Takeaways

Valuation shows Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A trading at a premium to the broader market with a P/E of -297.8.

Frequently Asked Questions

What is the current Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A (BRKRP) stock price?

Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A (NASDAQ: BRKRP) stock price is $323.59 in the last trading session. During the trading session, BRKRP stock reached the peak price of $329.72 while $323.42 was the lowest point it dropped to. The percentage change in BRKRP stock occurred in the recent session was -3.37% while the dollar amount for the price change in BRKRP stock was - $11.28.

BRKRP's industry and sector of operation?

The NASDAQ listed BRKRP is part of Medical - Devices industry that operates in the broader Healthcare sector. Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of BRKRP?

No Data

How BRKRP did perform over past 52-week?

BRKRP's closing price is 29.44% higher than its 52-week low of $250.00 where as its distance from 52-week high of $419.83 is -22.92%.

How many employees does BRKRP have?

Number of BRKRP employees currently stands at 11,396.

Link for BRKRP official website?

Official Website of BRKRP is: https://www.bruker.com

How do I contact BRKRP?

BRKRP could be contacted at phone 978 663 3660 and can also be accessed through its website. BRKRP operates from 40 Manning Road, Billerica, MA 01821, United States.

How many shares of BRKRP are traded daily?

BRKRP stock volume for the day was 6.72K shares. The average number of BRKRP shares traded daily for last 3 months was 15.18K.

What is the market cap of BRKRP currently?

The market value of BRKRP currently stands at $49.09B with its latest stock price at $323.59 and 151.7M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	11396
Beta	1.17
Sales or Revenue	N/A
5Y Sales Change%	N/A
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Medical - Devices

BRKRP Company Profile and Key Details

Bruker 6375% Mandatory Convertible Preferred Stock Series A

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Financial & Profitability Overview

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Dividend & Fair Value

Valuation Metrics

Financial & Profitability Overview

Price Forecast & Outlook

Key Takeaways